Primmune Therapeutics is a Biotechnology company.
Primmune Therapeutics has raised $8.6M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Primmune Therapeutics's investors include Samsara BioCapital, Polaris Partners, Oberland Capital, BioRock Ventures Name, Bioqube Ventures.
Primmune Therapeutics is headquartered in San Diego, United States.
Primmune Therapeutics is a Biotechnology company.
Primmune Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Primmune Therapeutics — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/primmune-therapeutics. Accessed July 20, 2026.
VCBacked. (2026). Primmune Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/primmune-therapeutics
{{cite web |title=Primmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/primmune-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated